Literature DB >> 18760933

Influence of sex and age on long-term survival in systematic off-pump coronary artery bypass surgery.

Raymond Cartier1, Olivier Bouchot, Ismail El-Hamamsy.   

Abstract

BACKGROUND: Off-pump coronary artery bypass surgery (OPCAB) is commonly used as an alternative to conventional on-pump coronary artery revascularization. Historically, sex and age have been shown to adversely affect operative mortality risk as well as long-term survival in conventional surgery. AIMS OF THE STUDY: To evaluate the effect of gender and ageing on long-term mortality following OPCAB surgery.
METHODS: We have prospectively followed up 1000 consecutive and systematic OPCAB patients operated between September 1996 and April 2003. Average follow-up period was 64+/-28 months and was complete in 98% of the cohort.
RESULTS: There were 223 women (21%) and 777 men (79%). Women were older, 68+/-10 versus 63+/-10 years (p<0.0001) and had higher prevalence of hypertension (p<0.0001), peripheral vascular disease (PVD) (p=0.03), recent myocardial infarction (p=0.04) and a smaller body surface (p<0.0001). History of congestive heart failure (CHF) (p=0.001) and unstable angina (p=0.003) was more frequent in men. Operative mortality was 2.8% in women and 1.4% in men (p=ns). Eight-year survival was 79+/-2.5% for men and 68+/-5% for women, (p=0.02). Cox regression analysis model revealed that age (HR: 2.81; 95% CI: 1.89-4.18), CHF (HR: 2.09; 95% CI: 1.33-3.31), PVD (HR: 1.72; 95% CI: 1.10-2.5), incomplete revascularization (HR: 2.35; 1.37-4.02), multiple internal thoracic artery (MITA) graft/patient (ITA/pt) (HR: 0.61; 95% CI: 0.44-0.84), left ventricular ejection fraction (LVEF) (HR: 0.19; 95% CI: 0.05-0.71) and cerebral vascular disease (HR: 1.50; 95% CI: 1.00-2.24) but not female sex (p=0.89) were significant predictors of long-term mortality. Above 65 years of age men and women had a comparable overall survival (p=0.7) whereas fewer than 65 women had a lower survival than men (p=0.001). Cox regression revealed that LVEF (HR: 0.06; 95% CI: 0.006-0.59), lesser use of MITA graft (HR: 0.45; 95% CI: 0.35-0.79), were significant causes of long-term mortality in the younger cohort. Female gender did not reach statistical significance (p=0.12).
CONCLUSION: In this series of systematic OPCAB surgery, the lower survival rate observed in younger women was mostly related to a higher prevalence of preoperative comorbidity and a lesser use of MITA grafts than gender itself.

Entities:  

Mesh:

Year:  2008        PMID: 18760933     DOI: 10.1016/j.ejcts.2008.07.024

Source DB:  PubMed          Journal:  Eur J Cardiothorac Surg        ISSN: 1010-7940            Impact factor:   4.191


  5 in total

1.  Gender gap in acute coronary heart disease: Myth or reality?

Authors:  Mette Claassen; Kirsten C Sybrandy; Yolande E Appelman; Folkert W Asselbergs
Journal:  World J Cardiol       Date:  2012-02-26

2.  Cost-effectiveness of a symptom management intervention: improving physical activity in older women following coronary artery bypass surgery.

Authors:  Lufei Young; Lani Zimmerman; Bunny Pozehl; Susan Barnason; Hongmei Wang
Journal:  Nurs Econ       Date:  2012 Mar-Apr       Impact factor: 1.085

3.  Association of gender with outcomes in critically ill patients.

Authors:  Kamran Mahmood; Kamal Eldeirawi; Momen M Wahidi
Journal:  Crit Care       Date:  2012-05-22       Impact factor: 9.097

4.  Risk factors for mortality of patients undergoing coronary artery bypass graft surgery.

Authors:  Carlos Alberto Dos Santos; Marcos Aurélio Barboza de Oliveira; Antônio Carlos Brandi; Paulo Henrique Husseini Botelho; Josélia de Cássia Menin Brandi; Marcio Antônio Dos Santos; Moacir Fernandes de Godoy; Domingo Marcolino Braile
Journal:  Rev Bras Cir Cardiovasc       Date:  2014 Oct-Dec

5.  Gender differences in outcomes following isolated coronary artery bypass grafting: long-term results.

Authors:  Francesco Nicolini; Antonella Vezzani; Daniela Fortuna; Giovanni Andrea Contini; Davide Pacini; Davide Gabbieri; Claudio Zussa; Rossana De Palma; Tiziano Gherli
Journal:  J Cardiothorac Surg       Date:  2016-09-30       Impact factor: 1.637

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.